Straits Times Index
3,338.94 -9.93 (-0.30%) S&P 500
5,283.88 +0.48 (+0.01%) Dow
38,674.17 +103.14 (+0.27%) Nasdaq
16,828.00 -0.67 (-0.00%) Bitcoin USD
70,151.37 +1,093.73 (+1.58%) CMC Crypto 200
1,472.67 +25.52 (+1.76%)
AMGN Jul 2024 345.000 call
| Previous close | 0.3800 |
| Open | 0.3800 |
| Bid | 0.5000 |
| Ask | 0.8000 |
| Strike | 345.00 |
| Expiry date | 2024-07-19 |
| Day's range | 0.3800 - 0.3800 |
| Contract range | N/A |
| Volume | |
| Open interest | 279 |
PR NewswireAMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
Amgen (NASDAQ:AMGN) will present at Jefferies Global Healthcare Conference at 9:00 a.m. ET on Thursday, June 6, 2024. Peter Griffith, executive vice president and chief financial officer at Amgen, and Ian Thompson, senior vice president, U.S. Business Operations at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
BenzingaAmgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Tuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to AstraZeneca Plc’s (NASDAQ:AZN) Soliris (eculizumab) to treat certain rare diseases. Bkemv is approved for the following treatment indications, which are also currently approved for Soliris: The treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis. The treatment of patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-medi
- Yahoo Finance Video
Nvidia, advances in cancer research, climate change under Trump: Market Domination
Nvidia (NVDA) continues to dominate the tech sector as the company's shares move past $1,100. The chip giant earned a boost from Elon Musk, who announced that xAI's supercomputer will run on Nvidia technology. Meanwhile, Tesla (TSLA) shareholders are awaiting an important vote on June 13, which will dictate the fate of Musk's proposed pay package of $56 billion. The American Society of Clinical Oncology (ASCO) will hold its annual meeting in Chicago this week, exploring the latest advancements in the cancer research sector. Tom Steyer, Galvanize Climate Solutions Co-Executive Chair, also joins the show to give insight into the state of climate change mitigation under a possible second Trump presidency. For more expert insight and the latest market action, click here.
